1. Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast
- Author
-
François Duhoux, Latifa Fellah, Claudia Maria Stanciu-Pop, Christine Galant, Mieke R. Van Bockstal, Marie-Cécile Nollevaux, Martine Berlière, UCL - SSS/IREC/MORF - Pôle de Morphologie, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/GYNE - Pôle de Gynécologie, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (MGD) Service d'anatomie pathologique, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service de gynécologie et d'andrologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Service de radiologie, and UCL - (SLuc) Centre du cancer
- Subjects
Adult ,0301 basic medicine ,In situ ,medicine.medical_specialty ,Pathology ,Stromal cell ,Biopsy ,Histopathology ,Breast Neoplasms ,Tumor-infiltrating lymphocytes ,Pathology and Forensic Medicine ,Necrosis ,03 medical and health sciences ,0302 clinical medicine ,Intratumor heterogeneity ,Predictive Value of Tests ,Patient age ,Humans ,Medicine ,Breast ,Nuclear atypia ,skin and connective tissue diseases ,neoplasms ,Molecular Biology ,Aged ,Retrospective Studies ,Aged, 80 and over ,Cell Nucleus ,Inflammation ,medicine.diagnostic_test ,business.industry ,Ductal carcinoma in situ ,Calcinosis ,Cell Biology ,General Medicine ,Middle Aged ,Ductal carcinoma ,body regions ,Carcinoma, Intraductal, Noninfiltrating ,030104 developmental biology ,030220 oncology & carcinogenesis ,Female ,Stromal Cells ,business - Abstract
Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease in terms of morphological characteristics, protein expression profiles, genetic abnormalities, and potential for progression. Molecular heterogeneity has been extensively studied in DCIS. Yet morphological heterogeneity remains relatively undefined. This study investigated morphological intratumor heterogeneity in a series of 51 large DCIS. Nuclear atypia, DCIS architecture, necrosis, calcifications, stromal architecture, and stromal inflammation were assessed in one biopsy slide and three representative slides from each corresponding resection. For each histopathological feature, a histo-score was determined per slide and compared between the biopsy and the resection, as well as within a single resection. Statistical analysis comprised of Friedman tests, post hoc Wilcoxon tests with Bonferroni corrections, Mann-Whitney U tests, and chi-square tests. Despite substantial morphological heterogeneity in around 50% of DCIS, the histopathological assessment of the biopsy did not statistically significantly differ from the resection. Morphological heterogeneity was not significantly associated with patient age, DCIS size, or type of surgery, except for a weak association between heterogeneous stromal inflammation and smaller DCIS size. At the group level, the degree of heterogeneity did not significantly affect the representativity of a biopsy. At the individual patient level, however, the presence of necrosis, intraductal calcifications, myxoid stromal changes, and high-grade nuclear atypia was underestimated in a minority of DCIS patients. This study confirms the presence of morphological heterogeneity in DCIS for all six evaluated histopathological features. This should be kept in mind when taking biopsy-based treatment decisions for DCIS patients.
- Published
- 2021